Science, Technology, Innovation, Programming, Progress.
proportion of subjects who achieve CR or PR. RECIST is widely used in clinical trials for solid tumors, but it has some limitations, such as not accounting for tumor heterogeneity, necrosis, or immunotherapy effects. Lugano: This is a classification system for lymphoma that is based on the Ann